BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC).
Saved in:
| Title: | BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC). |
|---|---|
| Authors: | Tan GYT; Molecular and Cell Biology, Taiwan International Graduate Program, Academia Sinica and National Defense Medical University, Taipei, 11490, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan., Lin PY; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan., Cheng LT; Molecular and Cell Biology, Taiwan International Graduate Program, Academia Sinica and National Defense Medical University, Taipei, 11490, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan., Tsai Yuan YS; Department of Chemistry, National Taiwan University, Taipei, 106319, Taiwan., Huang SH; Institute of Biochemical Sciences, National Taiwan University, Taipei, 106319, Taiwan., Yu CA; Institute of Molecular Biology, Academia Sinica, Taipei, 115201, Taiwan., Chen CT; Department of Chemistry, National Taiwan University, Taipei, 106319, Taiwan., Chi P; Institute of Biochemical Sciences, National Taiwan University, Taipei, 106319, Taiwan., Hwang-Verslues WW; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan. wendyhv@as.edu.tw. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2026 May; Vol. 18 (5), pp. 1933-1966. Date of Electronic Publication: 2026 Apr 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1757-4684 |
|---|---|
| DOI: | 10.1038/s44321-026-00414-8 |
